Reducing the risks of sudden death and heart failure post myocardial infarction: utility of optimized pharmacotherapy
J Sackner‐Bernstein - … Indexed and Peer‐Reviewed Journal for …, 2005 - Wiley Online Library
Current guidelines define the standard of care for patients after myocardial infarction (MI),
with particular focus on patients with significant ventricular dysfunction. Inherent in these …
with particular focus on patients with significant ventricular dysfunction. Inherent in these …
Practical algorithms for pharmacologic management of the post myocardial infarction patient
JA Reiffel - Clinical Cardiology: An International Indexed and …, 2005 - Wiley Online Library
The pharmacologic management of the patient post myocardial infarction (MI) aims to
achieve several goals. Chief among these is to prevent subsequent events, which include …
achieve several goals. Chief among these is to prevent subsequent events, which include …
Enhancing cardiac protection after myocardial infarction: rationale for newer clinical trials of angiotensin receptor blockers
MA Pfeffer - American heart journal, 2000 - Elsevier
Treatment of acute myocardial infarction (MI) has been advanced considerably in the past
20 years with the advent of acute reperfusion strategies such as thrombolytic therapy or …
20 years with the advent of acute reperfusion strategies such as thrombolytic therapy or …
Secondary prevention of myocardial infarction: Role of β-adrenergic blockers and angiotensin-converting enzyme inhibitors
WH Frishman, A Cheng - American Heart Journal, 1999 - Elsevier
β-Blockers reduce cardiovascular death and reinfarction in patients with a history of
myocardial infarction (MI), and angiotensin-converting enzyme (ACE) inhibitors provide an …
myocardial infarction (MI), and angiotensin-converting enzyme (ACE) inhibitors provide an …
[PDF][PDF] Beta-adrenergic blocking agents or angiotensin-converting enzyme inhibitors, or both, for postinfarction patients with left ventricular dysfunction
RA O'Rourke - Journal of the American College of Cardiology, 1997 - core.ac.uk
The use of pharmacologic agents for the secondary prevention of sudden and non-sudden
death and recurrent myocardial infarction (MI) in patients who survive an acute MI has …
death and recurrent myocardial infarction (MI) in patients who survive an acute MI has …
Traditional heart failure medications and sudden cardiac death prevention: a review
MO Al Chekakie - Journal of cardiovascular pharmacology …, 2013 - journals.sagepub.com
Sudden cardiac death (SCD) is still a major public health issue with an estimated annual
incidence ranging from 184,000 to> 400,000 per year. The ACC/AHA/ESC 2006 guidelines …
incidence ranging from 184,000 to> 400,000 per year. The ACC/AHA/ESC 2006 guidelines …
Early use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: evidence from clinical trials
GV Moukarbel, SD Solomon - Current heart failure reports, 2008 - Springer
Following acute myocardial infarction, patients are at increased risk of developing heart
failure, which is more prevalent in those with reduced ventricular systolic function. Activation …
failure, which is more prevalent in those with reduced ventricular systolic function. Activation …
Pharmacotherapy following myocardial infarction-a review of current treatment practices
S Ørn, K Dickstein - Expert Opinion on Pharmacotherapy, 2000 - Taylor & Francis
Modern treatment of acute myocardial infarction (AMI), including thrombolysis and early
interventional strategies, has reduced mortality rates but increased the number of patients …
interventional strategies, has reduced mortality rates but increased the number of patients …
Evaluation and treatment strategies in patients at high risk of sudden death post myocardial infarction
RD Underwood, J Sra, M Akhtar - Clinical cardiology, 1997 - Wiley Online Library
Over 50 percent of deaths in patients who survive an acute myocardial infarction are due to
fatal ventricular tachyarrhythmias. Patients who survive an episode of sustained ventricular …
fatal ventricular tachyarrhythmias. Patients who survive an episode of sustained ventricular …
The secondary prevention of myocardial infarction
AD Michaels - Current problems in cardiology, 1999 - Elsevier
~ espite significant improvement in primary prevention and management, acute myocardial
infarction remains a major public health problem in the United States and most industrial …
infarction remains a major public health problem in the United States and most industrial …
相关搜索
- myocardial infarction secondary prevention
- myocardial infarction sudden death
- heart failure sudden death
- myocardial infarction heart failure
- optimized pharmacotherapy sudden death
- myocardial infarction optimized pharmacotherapy
- heart failure optimized pharmacotherapy
- myocardial infarction enzyme inhibitors
- myocardial infarction treatment practices
- myocardial infarction cardiac protection